TPST

NASDAQ

Tempest Therapeutics

$1.56
+0.00 (+0.00%)
Institutional
29.4%
Insider
35.37%
Retail/Other
35.2%
Shares Outstanding
14.3M

Top Institutional Holders

As of Apr 2026
Holder Shares % Change
Sabby Management LLC 277K 6.2% +0.3M
Versant Venture Management LLC 270K 6.1% +0.0M
Versant Venture Management LLC 270K 2.0% -
Versant Venture Management LLC 270K 2.0% -
Sabby Management LLC 179K 1.3% +0.2M
Vanguard Group Inc 163K 1.2% -
TANG CAPITAL MANAGEMENT LLC 139K 3.1% +0.1M
Vanguard Group Inc 135K 3.0% +0.1M
Geode Capital Management, LLC 44K 0.3% +0.0M
Geode Capital Management, LLC 41K 0.3% +0.0M

Insider Transactions

Last 24 months (1 insiders)
Matthew Angel CEO and President
231,482 shares
231K0116KMar 2026Mar 2026
Buys (1)
Shares Price Value Date Remaining
231,482 $2.16 $500,001 2026-03-24 231,482

Insider Activity Summary

Last 24 months
Total Bought
231,482 shares
$500,001
Total Sold
0 shares
$0
Net Shares
+231,482
Net Value
$+500,001
Activity by Insider
Name Bought Sold Net Shares Net Value
Matthew Angel
CEO and President
 +231,482 - +231,482 $+500,001
Net insider buying: 231,482 shares ($500,001) in last 12 months

Congressional Trading

STOCK Act Disclosures

No congressional trading data available for this ticker.

Congressional trading data is sourced from STOCK Act disclosures and may not be available for all tickers.

Based on public disclosures. Reporting errors by representatives are common. Disclosure deadlines are 45 days after transaction.